Signal Refinement of Drug-Induced Thrombocytopenia using The Health Information Network (THIN) Database

Oct-13

AUTHORS : Manfred Hauben, Pfizer, 219 East 42nd Street, New York, NY 10017, USA – Email: manfred.hauben@Pfizer.com OR Andrew Bate, Pfizer Ltd., Worldwide Safety and Regulatory Epidemiology, United Kingdom – Email: andrew.bate@pfizer.com – Profile (ISOP): https://isoponline.org/about-isop/andrew-bate/

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 22(S1):225

DOI : 10.1002/pds.3512

Signal Refinement of Drug-Induced Thrombocytopenia using The Health Information Network (THIN) Database

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study